In the current study, we probed in detail the functioning of a NEAT1/miR-129-5p/PEG3 axis in NASH and identified the underlying mechanisms with the NF-κB signaling pathway, which may guide research toward much-needed new approaches for the treatment for NASH. Here, NFKB1 is linked to metabolic dysfunction-associated steatohepatitis.